Civil Servants Often Work for Administrations They Disagree with Politically. How Does This Affect Their Job Performance?
While the benefits of insulating career bureaucrats are clear, new research explores whether there are downsides, too.
A new study helps explain societies’ deeply polarized views on bias and discrimination.
The answer may lie in how pharmaceutical companies are targeting their R&D spending.
As healthcare gets more complex—and more expensive—business models are adapting to address misaligned interests and incentives.
Former NSA Director Adm. Michael Rogers on why your company could be a target—and what you should do about it.
There are tangible benefits for quality of care when hospitals compete for higher-paying patients.
A Kellogg professor explains the new appetite for large public investment—and how the American Jobs Act would deliver.
From stocking grocery store shelves to pricing plane tickets, here’s what to expect.
When It Comes to Investing in Product Innovation, Large CPG Companies Could Learn a Lot from Their Smaller Competitors
New research suggests that, instead of aiming for big breakthroughs, large companies should focus on incremental but meaningful improvements.
Organizations should be leery of putting high-status leaders beyond scrutiny.
While previous studies suggested a negative impact, new, more precise research shows these students often boost their U.S.-born peers’ test scores
“When your largest shareholders create a ruckus, you listen.”
The case for why central banks and policymakers must jump in the race now or risk getting left behind.
Two professors share research-backed tips for rethinking your recruiting efforts and getting the most out of diversity training.
On this episode of The Insightful Leader: a blueprint for making strong (and honest) arguments with data.
A chief medical officer and a supply-chain expert discuss the nuances of the rollout.
The common (and mistaken) belief that we generate our best ideas early can actually squash creativity.